This is to inform you that the Board of Directors of the Company have, on 28th November, 2024 inter-alia, approved to acquire 10,000 ordinary shares of Singapore Dollar 1/- each of Sudarshan Pharma Industries Private Limited, a company incorporated in Singapore (Unique Entity Number: 202327475M) (100% of the paid-up share capital of Sudarshan Pharma Industries Private Limited). Upon completion of the acquisition, Sudarshan Pharma Industries Private Limited, Singapore would become a wholly owned subsidiary of the Company